重大利好消息来袭！ A股市场今年首个10倍涨幅的个股已经诞生，它就是被市场猜测可能成为智元机器人借壳对象的上纬新 材。 自7月9日智元机器人公布战略收购计划后，上纬新材的股价在短短14个交易日内就飙升了10倍，这一表 现无疑点燃了市场对人形机器人借壳上市概念的热情。 可以预见，人形机器人借壳上市这一投资主线，将催生更多的10倍涨幅神话！ 在这波热潮中，有一家备受瞩目的具身智能领域黑马企业，它正吸引着众多行业专家和投资者的目光， 极有可能成为下一个借壳上市的人形机器人行业领军者，继续书写资本市场的传奇篇章。 这家企业，就是乐聚机器人。 如果你错过了上纬新材的飙涨，那么这家与乐聚机器人关系紧密、潜力无限的个股，绝对不容错过。它 不仅直接参与了乐聚机器人的D轮融资，还与乐聚达成了全产业链的战略合作。 那么，为何说乐聚机器人有望成为继智元之后，下一个借壳上市的人形机器人巨头呢？ 答案在于乐聚在行业内的卓越地位和技术实力。作为国家人形机器人产业化的重要推动者，乐聚在机器 人技术方面取得了显著突破。其研发的模块化关节技术，显著提升了机器人的动作灵活性和精准度；而 全身动量控制算法则能动态调整机器人动作，确保其在各种环境下 ...

Market Overview - A-shares experienced a significant afternoon rally, with the Shanghai Composite Index regaining above 3600 points, closing up 0.33% at 3609.71 points, while the ChiNext Index rose nearly 2% to 2406.59 points, marking a new high for the year [1] - The total trading volume in the Shanghai and Shenzhen markets reached 182.96 billion yuan, an increase of approximately 63 billion yuan compared to the previous day [1] Sector Performance - The insurance and banking sectors saw declines, while the semiconductor sector surged, with Dongxin Co. hitting a 20% limit up and Fudan Microelectronics rising nearly 10% [1] - The steel sector also showed strong performance, with Xining Special Steel and Bayi Steel reaching their daily limit up [1] - The innovative drug concept experienced a resurgence, with Sanmiao Gene rising over 20% and several other pharmaceutical stocks hitting their daily limit up [1][3] Notable Stocks - WuXi AppTec reported a 96.20% year-on-year increase in total profit and a 101.92% increase in net profit attributable to shareholders for the first half of the year, with a backlog of orders amounting to 56.69 billion yuan, a 37.2% increase year-on-year [4][5] - The stock of Weiwai New Materials surged over 10 times since July, reaching a new high of 90 yuan per share, although the company cautioned that its stock price has significantly deviated from its fundamental situation [10] Future Outlook - WuXi AppTec expects its revenue from ongoing operations to return to double-digit growth, with an upward adjustment of its overall revenue forecast to between 42.5 billion and 43.5 billion yuan [5] - The innovative drug industry is anticipated to enter a new phase, with significant opportunities expected in 2025, driven by upcoming international conferences and ongoing licensing transactions [6] Semiconductor Sector Insights - The semiconductor sector saw strong gains, with Dongxin Co. and Fudan Microelectronics leading the charge [7] - The U.S. government's recent AI Action Plan aims to bolster domestic semiconductor manufacturing while imposing restrictions on exports, which may accelerate the domestic industry's self-sufficiency [9]

今日（7月29日），A股午后拉升走高，沪指重返3600点上方，创业板指涨近2%站上2400点续创年内新 高；港股走势疲弱，但尾盘跌幅有所收窄。 具体来看，沪指早盘窄幅震荡，午后拉升收复3600点，深证成指、创业板指均大幅走高。截至收盘，沪 指涨0.33%报3609.71点，深证成指涨0.64%报11289.41点，创业板指涨1.86%报2406.59点，科创50指数涨 1.45%，沪深北三市合计成交18296亿元，较此前一日增加约630亿元。 另外，恒瑞医药28日披露，公司与GSK（葛兰素史克）达成协议，将HRS-9821项目的全球独家权利和 至多11个项目的全球独家许可的独家选择权有偿许可给GSK。GSK将向恒瑞支付5亿美元的首付款，如 果所有项目均获得行使选择权且所有里程碑均已实现，恒瑞将有资格获得未来基于成功开发、注册和销 售里程碑付款的潜在总金额约120亿美元。 兴业证券指出，当前我国创新药行业处于3.0时代，从"跟跑者"到"引领者"，2025年成为中国创新药海 外爆品爆发的元年，大量峰值超过30亿—50亿美元的品种浮出水面，对外授权交易不断刷新纪录。预计 今年产业趋势带来的投资机会大于2020—20 ...

Market Overview - The Shanghai Composite Index closed up 0.33% at 3609.71 points, while the Shenzhen Component Index rose 0.64% to 11289.41 points, and the ChiNext Index increased by 1.86% to 2406.59 points. The total trading volume in the Shanghai and Shenzhen markets reached 182.96 billion yuan, an increase of approximately 63 billion yuan from the previous day [1] Sector Performance - The insurance and banking sectors experienced declines, while the semiconductor sector saw significant gains, with Dongxin Co. hitting a 20% limit up and Fudan Microelectronics rising nearly 10% [1] - The steel sector was also active, with Xining Special Steel and Bayi Steel reaching their daily limit up [1] - The innovative drug concept surged, with Sanyuan Gene rising over 20%, and several other pharmaceutical companies hitting their daily limit up [1][4] Innovative Drug Sector - The innovative drug sector saw a broad rally, with notable gains including Sanyuan Gene up over 20%, Ruizhi Medicine hitting the limit up, and WuXi AppTec increasing nearly 8% [4][6] - WuXi AppTec reported a 96.20% year-on-year increase in total profit and a 101.92% increase in net profit attributable to shareholders for the reporting period. The company expects a revenue growth rate adjustment from 10%-15% to 13%-17% for 2025 [6][7] Semiconductor Sector - The semiconductor sector showed strong performance, with Dongxin Co. hitting a 20% limit up and Fudan Microelectronics rising nearly 10% [9] - The U.S. government's recent AI Action Plan aims to accelerate the development of the AI industry while imposing stricter export controls on AI computing power and semiconductor manufacturing, which may accelerate domestic self-sufficiency efforts in China [11] Notable Stocks - The stock of Upwind New Materials surged, breaking the 90 yuan mark and reaching a new historical high, with a cumulative increase of over 10 times since July [13] - The company emphasized that its fundamental business has not undergone significant changes, despite the stock price surge [13]

"10倍股"上纬新材（688585）今天盘中股价再创历史新高，但走势波动较大。该股今天上涨6.19%，今年以来累计涨1169%。 上午，上纬新材一度涨近18%，午后股价缓慢回落，13:42左右，股价突然直线跳水翻绿，后又大幅拉升，一度涨超15%，临近尾盘，股价再度跳水。今 天，上纬新材成交额超21亿元。 算力和创新药板块走强 近期，算力、创新药及其上游的CXO板块持续走强。今天，这两大板块再度大涨。 CRO板块今天领涨，睿智医药、药石科技等个股大涨。两大龙头股药明康德、恒瑞医药分别上涨7.72%、2.84%。 7月29日，A股三大指数全线飘红，创业板指站上2400点。 截至收盘，上证指数上涨0.33%，深证成指上涨0.64%，创业板指上涨1.86%，报2406.59点。全市场成交额约1.83万亿元。 上纬新材巨震 一是各板块的龙头股持续走强，每天都有不少龙头股刷新历史新高。今天，新易盛、中际旭创、生益科技、胜宏科技、仕佳光子、沪电股份、工业富联、 苑东生物、益方生物、芯碁微装、电气风电等个股盘中股价创历史新高。 二是市场更加聚焦大市值和中市值的龙头股。 | | | 874.62 4.00% | | | | - ...

截至收盘，上证指数上涨0.33%，深证成指上涨0.64%，创业板指上涨1.86%，报2406.59点。全市场成交额约1.83万亿元。 上纬新材巨震 "10倍股"上纬新材（688585）今天盘中股价再创历史新高，但走势波动较大。该股今天上涨6.19%，今年以来累计涨1169%。 7月29日，A股三大指数全线飘红，创业板指站上2400点。 上午，上纬新材一度涨近18%，午后股价缓慢回落，13:42左右，股价突然直线跳水翻绿，后又大幅拉升，一度涨超15%，临近尾盘，股价再度跳水。今 天，上纬新材成交额超21亿元。 算力和创新药板块走强 近期，算力、创新药及其上游的CXO板块持续走强。今天，这两大板块再度大涨。 CRO板块今天领涨，睿智医药、药石科技等个股大涨。两大龙头股药明康德、恒瑞医药分别上涨7.72%、2.84%。 | | | 874.62 4.00% | | | | --- | --- | --- | --- | --- | | 成分股 | 基金 | 资金 | 板块分析 | 新闻 | | ●展开分析 | | 最新 | 涨幅 ◆ | 流通市值 | | 睿智医药 | | 13.61 | 20.02% | 67.7 ...

7月28日，A股诞生了今年之内的第一只十倍股：上纬新材。上证指数近期突破3600点创下年底新高，沪深300指数也达到年内高点，MSCI中国指 数更是创下四年新高。 在当前市场情绪升温的背景下，大家最关心的问题是：下半年市场还能持续走强吗？ 针对大家关心的核心问题，我们邀请广发证券首席策略分析师刘晨明，在本周日（8月3日）上午来主讲一次Alpha线上闭门私享会，跟大家研讨交 流：2025下半年A股牛市"引爆点"在哪里？哪些资产最值得关注？ 刘晨明在2023、2024年连获新财富最佳策略分析师第一名，是当前市场上最有影响力的A股策略分析师。他在2024年联手华尔街见闻打造的大师 课《A股策略方法论》也广受用户好评。 对本周日刘晨明老师闭门分享活动感兴趣的朋友，可以点击下方活动海报报名加入Alpha线上闭门私享会会员，一起来听听他对市场的最新洞察。 Alpha线上闭门私享会是华尔街见闻针对高净值用户提供的服务，2025年全年将举行至少20场Alpha线上闭门私享会，平均每季度举行5场。我们会 针对大家关心的市场热点及核心问题，邀请全球一线大咖来进行线上闭门分享，并为用户答疑解惑，帮大家看清资产变动风向，助力个人关键 ...

Group 1 - RuiLian New Materials plans to terminate the raw material project of Weinan RuiLian Pharmaceutical due to uncertainties in the construction timeline of the second phase [1] - HaiDa Group reported a net profit of 2.639 billion yuan for the first half of 2025, a year-on-year increase of 24.16% [1] Group 2 - JinCheng Pharmaceutical's subsidiary received the CEP certificate for Oseltamivir phosphate chemical raw material from the European Medicines Agency [2] - WenFeng Co. announced that 124 million shares held by shareholder Zheng SuZhen will be judicially auctioned [3] Group 3 - ShanJin International plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [5] - XiDian Pharmaceutical's shareholders plan to reduce their holdings by up to 3% of the company's total shares [7] Group 4 - ZhongTung High-Tech's subsidiary intends to purchase assets from Wukuang Tungsten Industry for 135 million yuan [9] - ZhongTung High-Tech's subsidiary plans to implement a 1.4 billion micro-drill intelligent manufacturing project with an estimated total investment of 178 million yuan [10] Group 5 - TianYi Co. has been selected as the first candidate for two procurement projects by China Mobile, with a total share of 160% [11] - GuangKu Technology is planning a major asset restructuring and has suspended trading of its stock [13] Group 6 - FaShiLong's controlling shareholder plans to transfer part of its shares, with the stock resuming trading [14] - TaiGe Pharmaceutical's shareholder plans to reduce holdings by up to 3 million shares [15] Group 7 - DaLian ShengYa's controlling shareholder is set to change, with the stock resuming trading [16] - JuRan Smart Home announced the passing of its actual controller and CEO, Wang LinPeng [18] Group 8 - JingQuanHua's shareholder plans to reduce holdings by up to 1% of the company's total shares [19] - JiangTe Electric's control change has progressed, with the stock resuming trading [21] Group 9 - AiWei Electronics plans to issue convertible bonds to raise up to 1.901 billion yuan for various projects [22] - ShangWei New Materials stated that its stock price has significantly deviated from its current fundamentals [22] Group 10 - JingHe Integrated plans to invest 1.195 billion yuan in Anhui Jingmei to support its layout in the photomask industry [23]

Group 1 - The first 10-fold stock in A-shares this year is Upwind New Materials, which is expected to be reverse listed by Zhiyuan Robotics, having increased tenfold in just 14 trading days since the announcement of the strategic acquisition on July 9 [1] - There is a strong expectation for more 10-fold stocks to emerge in the humanoid robotics sector, indicating a potential capital legend in the industry [1] - Upwind New Materials is seen as a promising player in the humanoid robotics market, attracting attention from industry insiders and investors alike [1] Group 2 - Leju Robotics is identified as a potential stock that may be reverse listed next, having participated in D-round financing and signed a full industry chain strategic cooperation with Leju [3] - Leju Robotics has established an unshakeable leading position in the industry and is a pioneer in the national humanoid robotics industrialization [3] - The modular joint technology developed by Leju significantly enhances the flexibility and precision of robot movements, while the full-body momentum control algorithm ensures stability [3] Group 3 - Leju has achieved a major breakthrough in the localization of core components, with the localization rate of the third-generation "Kuafu" core components exceeding 90%, thus building a self-controllable supply chain [4] - Leju Robotics has completed the industrial delivery of 100 humanoid robots, making it the company with the highest number of deliveries globally [4] - The company has strategic agreements with other firms, such as Koli'er and Fujia, to provide core components and manufacturing support for Leju Robotics [4] Group 4 - The company holds a 2.83% stake in Leju Robotics, indicating a strategic investment and potential for future growth [4] - The company is responsible for the large-scale production and after-sales service of Leju's humanoid robots, which gives it control over hardware manufacturing [4] - The current stock price is just over ten yuan, with a market capitalization of less than 16 billion, suggesting significant potential for a tenfold increase [4]

Market Overview - The A-share market experienced narrow fluctuations on July 29, with the ChiNext index rising over 1% at one point. Key sectors leading the gains included communication equipment, pharmaceuticals, and semiconductors, while agriculture, chemical fiber, hospitality, and logistics sectors lagged behind [1] - The Hong Kong stock market saw a decline, with the Hang Seng Index dropping more than 1%. Notable decliners included Xiaomi Group-W and ZTO Express-W, while WuXi AppTec and CSPC Pharmaceutical Group led the gains [1] Baby and Child Concept Surge - The baby and child concept stocks saw a significant surge today, driven by the announcement of a national childcare subsidy plan, which provides 3,600 yuan per child per year for children under three years old [2][6] - In the A-share market, Sunshine Dairy reached its daily limit, while Beingmate surged initially to its limit and closed up over 6%. Other notable gainers included Kidswant and Ai Ying Shi, both rising over 4% [3][4] - In the Hong Kong market, China Child Network saw its stock price rise by over 130% at one point, closing up over 70%. Other stocks like Ausnutria and Future Development Holdings also experienced gains [5] Subsidy Implementation Details - The childcare subsidy will be issued annually, with the current base standard set at 3,600 yuan per child per year. For children born before January 1, 2025, the subsidy will be calculated based on the number of eligible months [6] - The subsidy is exempt from personal income tax and will not be counted as income for families or individuals when determining eligibility for minimum living security or assistance programs [6] Industrial and Company Highlights - Industrial Fulian's stock price reached a historical high today, with an intraday increase of over 5%, pushing its market capitalization beyond 600 billion yuan [6] - On July 28, a notice regarding abnormal stock trading was issued for Aowei New Materials, indicating that the stock price had significantly deviated from its fundamental value, with multiple warnings issued regarding trading risks [8] - Aowei New Materials' stock has seen a cumulative increase of over 1,200% this year, with intraday gains exceeding 17% today [10]